ClinicalTrials.gov
public full text
Public Domain
Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D
The purpose of this study is to determine whether verapamil can transiently improve beta cell function in those who do or do not secrete proinsulin and little/no C-peptide.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Different Early Intensive Therapies on Long-term β-cell Function#249562
- Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient Cells#384798
- Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI#906991
- A novel FLNA p.Pro2469Ser variant is associated with impaired T and NK cell function and immune dysregulation.#650395
- Loss of NGAL protects against albumin-induced kidney inflammation and fibrosis#7924
Record · ID 1140778
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive